Enliven Therapeutics Inc - US
13F holders, Q3 2024 (September 30)1holders
1famous investor
$25.54avg. 13F price*
At the end of Q3 2024, 1 institutions reported holding Enliven Therapeutics Inc - US in their 13F filings. The largest holder was Tudor Investment Corporation ($243K). One famous investor held it Paul Tudor Jones (0.0% of Tudor Investment Corporation's portfolio).
- Company
- Enliven Therapeutics Inc - US
- CUSIP
- 29337E110
- Latest filing quarter
- Q3 2024
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $243K |
| Exits | 0 | $0 |
Ownership 1 holders
| Tudor Investment Corporation | 0.00% | New | 9,506 | $243K |
"% of holder's portfolio" is Enliven Therapeutics Inc - US's weight in each manager's 13F, not the share of Enliven Therapeutics Inc - US the manager owns.